In subclones of the human colon cancer LoVo cell line, there is a reproducible spontaneous transition from an epithelioid (E) to a round (R) morphotype. The E to R transition is associated with increased cell growth, absence of E-cadherin-dependent compaction in a slow aggregation assay, loss of contact inhibition of motility and directional migration in a wound filling motility assay. Furthermore, none of the E subclones from LoVo was invasive into chick heart fragments. This is in contrast to the R subclones that were either nonadherent or adherent and invasive. Macroarray analysis demonstrated transcriptional downregulation of plakoglobin in R type LoVo cells and this was confirmed at the level of the mRNA by quantitative RT-PCR. Western blotting showed lower expression of all components of the E-cadherin/catenin complex in R subclones. Interestingly, treatment of R subclones with the demethylating agent 5-aza-2 0 -deoxycytidine resulted in restoration of the E morphotype, higher expression of E-cadherin, but not plakoglobin mRNA, and higher expression of E-cadherin and plakoglobin at the protein level.
Introduction
The acquisition of invasiveness is a crucial step in the malignant progression of cancer. At the stage of the transition between the noninvasive adenoma towards the invasive carcinoma, the tumor consists not only of neoplastic epithelial cells but also contains a variety of host cells. Together these cells form a dynamic microecosystem in which the neoplastic cells may become constitutively or conditionally invasive (Mareel and Leroy, 2003) . Although derived from invasive primary carcinomas or from metastases, many colorectal cancer cell lines are noninvasive in different in vitro invasion assays. It is well known that invasive variants often lay dormant as a pre-existing minority population in heterogeneous cell lines (Brattain et al., 1981; Tomita et al., 1992; Kinsella et al., 1994; Vermeulen et al., 1995a Vermeulen et al., , 1999b . The in vitro acquisition of an invasive phenotype has been associated with the transition from an epithelioid (E) to a round (R) or fibroblastic (F) morphotype on solid substratum (Mareel et al., 1981 (Mareel et al., , 1986 ; Van den Broecke et al., 1996) and changes in the expression of components of the E-cadherin/catenin complex (Kinsella et al., 1994; Vermeulen et al., 1995a; Vermeulen et al., 1999b) .
In the present study, we focus on the human colorectal cancer LoVo cell line, for three reasons. First, we found differences in invasiveness in chick heart fragments between LoVo cell lines obtained from different laboratories. Second, it was reported that invasive variants could be isolated from heterogeneous LoVo cell lines (Aznavoorian et al., 1990; Re´my et al., 1992; Dumortier et al., 1998) . Third, the LoVo cell line is a genetically unstable cell line. This genetic instability consists of chromosomal instability (CIN) and a 'microsatelite instability-high' (MSI-H) phenotype, the latter being caused by inactivation of the hMSH2 mismatch repair gene (Lengauer et al., 1997) . Previously, we found that transition from the E to the R phenotype in HCT-8 colorectal cancer cells was caused by the combination of an MSI-H phenotype and mutational inactivation of the gene encoding aE-catenin (CTNNA1), which is a component of the E-cadherin/ catenin complex (Vermeulen et al., 1999a, b) . We, therefore, studied the possibility of a similar E to R transition in the LoVo cell line. In this report, we describe the establishment and the functional and molecular characteristics of several noninvasive and invasive variants of the human colorectal LoVo cancer cell line and show that the E to R transition is associated with reversible downregulation of all components of the E-cadherin/catenin complex.
Results

Morphotypical heterogeneity and transition from the E to the R morphotype
LoVo-92 and LoVo variants, which had either an E or an R morphotype on solid substratum, were cloned from the LoVo-92 and LoVo cell lines, and from harvest cultures from the respective cell lines and their subclones (Figure 1 ). R cells were less spread and showed refractile perikarya in phase contrast microscopy. The LoVo-92 cell line has a heterogeneous morphotype in which both E and R cells can be observed (Figure 2a ). The LoVo cell line has a more homogeneous E morphotype, although occasional R cells can be detected in the cultures (Figure 2b ). We could detect E and R subclones in harvest cultures of the cell lines LoVo-92 and LoVo. We cloned R variants from harvest cultures of three clonal E cell lines (LoVo E12, LoVo E15 and LoVo-92 E1; Figures 1 and 2 ). Although islands with an E morphotype were detected in cultures of clonal R variants, we were unable to clone E cell lines from the R variants. E clones formed domes in confluent monolayers, indicating that there is epithelial organization (data not shown). R clones on the other hand showed multilayer growth upon subconfluency (Figure 2d ).
It has been reported that an aE-catenin-negative R variant of the human colon cancer cell line HCT-8 acquired an E morphotype upon activation of protein kinase C (PKC) with 12-O-tetradecanoyl-phorbol-13-acetate (TPA) via the induction of desmosomes (van Hengel et al., 1997) . Therefore, we treated LoVoE15R1 and LoVo-92E1R1 with 250 ng/ml TPA during 4 h. The morphotype of the cultures treated shortly with TPA and coded led the unbiased observer to categorize them as E-variants rather than as R-variants (Figure 2e ). The R to E reversion, with epithelioid cells more closely packed, was also realized when LoVo-92E1R1 and LoVoE15R1 cells were treated with 5-aza-2 0 -deoxycytidine for 3-7 days (Figure 2f ), suggesting the involvement of promoter methylation. 5-Aza-2 0 -deoxycytidine had, however, no effect on the morphotype of cells when confluency was reached.
Following subcutaneous injection into the lateral flank of nude mice, both LoVo-92 and LoVo-92R4 produced tumors, but no metastases (data not shown). The cell line LoVo-92R4TD (derived from a subcutaneous tumor from LoVo-92R4) kept the R morphotype of LoVo-92R4.
Growth
We compared the growth of two clonal R cell lines with the growth of the clonal E cell lines from which they were, respectively, derived (LoVo-92E1R1 versus LoVo-92E1 and LoVoE15R1 versus LoVoE15). The cell lines LoVo-92E1R1 and LoVoE15R1 had lower doubling times and higher saturation densities then their respective parental E cell lines (Table 1) .
Aggregate formation
All the investigated E variants (LoVo-92E1, LoVoE12 and LoVoE15) formed compact multicellular spheroids when they were cultured for 3 days on a Gyrotory shaker. This was in contrast with the R variants (LoVo-92R4 and LoVoR14 and LoVoE15R1) that formed loosely organized multicellular spheroids when cultured on a Gyrotory shaker. The compact multicellular spheriods were resistant to dissociation by pipetting, while the loose multicellular spheriods were sensitive to pipetting (data not shown). The parental cell lines LoVo and LoVo-92 showed mixed multicellular spheriod populations.
In the slow aggregation assay, all the cell lines studied formed aggregates ( Figure 3 and Table 2 ). However, E-variant aggregates showed more compaction than R-variant aggregates. The parental cell lines LoVo and LoVo-92 formed heterogeneous aggregates consisting of a mixed population of compact and loose aggregates (Table 2) . Treatment with antibody MB2, functionally blocking E-cadherin, resulted in lack of compaction in the E variants, but did not interfere with aggregation ( Figure 3 and Table 2 ).
Wound-filling capacity
To study contact inhibition of membrane ruffling and the capacity to perform directional migration of the LoVo variants, we used a wound-filling motility assay. The E variant LoVo-92E1 and LoVoE15 monolayers filled in the wound after several days, while the R variant LoVoE15R1 and LoVo-92E1R1 monolayers migrated slower into the wound (Figure 4 ).
Invasion in vitro
All the E variants adhered to embryonic chick heart fragments in vitro. Histology showed that E cell lines are noninvasive and form an epithelioid layer around the heart tissue (Table 3 and Figure 5a ). This was in contrast with the R variants that either are adherent and invasive or nonadherent (Table 3 and Figure 5b) . Interestingly, the cell line LoVo-92 was invasive in the chick heart, while the cell line LoVo was noninvasive (Table 3) .
Cell-cell adhesion complexes
Immunocytochemistry showed a weaker signal or a disturbed pattern of adhesion molecules from tight junctions (ZO-1), desmosomes (desmoplakin) and adherens junctions (E-cadherin, aE-catenin, b-catenin, p120 ctn ) ( Figure 6 ). Furthermore E-cadherin-negative cells were detected in the R variants ( Figure 6 ). Western blotting of total lysates and of immunoprecipitations showed a weaker expression for E-cadherin aE-catenin, b-catenin, p120
ctn and plakoglobin in R as compared to (Figure 7a ). We found however not a single clone that completely lost its E-cadherin expression. Coimmunoprecipitation with an antibody against bcatenin showed that less E-cadherin and aE-catenin coprecipitated with b-catenin ( Figure 7b ). There were no differences in the expression of ZO-1, ZO-2 or occludin assessed by immunoprecipitation in LoVo-92E1 and LoVo-92E1R1 cells (data not shown).
The honeycomb pattern of ZO-1 and desmoplakin, but not of E-cadherin, could partially be restored in R variants by treatment with TPA (See Figure 6 ), indicating relocalization of these proteins. Treatment with 5-aza-2 0 -deoxycytidine resulted in upregulation of Ecadherin and plakoglobin proteins in R variants as evidenced by Western blotting of total lysates ( Figure 8a ).
To catalogue the changes at the mRNA level responsible for the acquisition of invasiveness in LoVo-92E1R1 cells, we used the cDNA macroarray technique. The Atlas Human Cell Interaction Array is spotted with 265 genes implicated in human cell-cell and cell-matrix interactions. Among these, six genes were identified that were differentially expressed in LoVo-92E1R1 cells as compared with their expression in LoVo-92E1 cells (Table 4 ). The differential expression of plakoglobin observed in the cDNA macroarray analysis was confirmed using quantitative RT-PCR. The expression of E-cadherin mRNA, which could not be determined from the cDNA macroarray because the signals were too weak, was also lower in LoVo-92E1R1 cells as compared to Lovo-92E1 cells (Figure 8b ). Moreover, 5-aza-2 0 -deoxycytidine treatment of LoVo-92E1R1 cells resulted in upregulation of E-cadherin mRNA, but not plakoglobin mRNA. This suggests implication of E-cadherin, but not plakoglobin, promoter methylation also in LoVo-92E1R1 cells. The presence of CDH1 promoter methylation using methylation-specific PCR was shown in LoVoE15R1 in Invasion was scored as follows: I, cancer cells were separated from the cardiac muscle by fibroblastic cells; II, cancer cells were apposed to the cardiac muscle (noninvasive); III, occupation of less than half the heart tissue by cancer cells (invasive); IV, occupation of more than half the heart tissue by cancer cells (invasive); 0, no evaluation of invasion. 4 In confronting cultures a few sections show cells inside the heart tissue contrast with LoVoE15, but neither in LoVo-92E1 nor in LoVo-92 E1R1 (data not shown).
Discussion
Loss of epithelioid organization in cell lines is a characteristic of malignant transformation and has been related to the acquisition of invasiveness and poor differentiation of tumors. We were able to isolate LoVo subclones with different morphotypes and to demonstrate that there is a transition from the E to the R morphotype in vitro in clonal cell populations. The parental LoVo cell line is an interesting tool to study loss of epithelioid organization, since it is a well-differentiated cell line that presents most of the properties of intestinal cells such as formation of acinar structures, microvilli, a glycocalix, desmosomes, adherens junctions and tight junctions (Drewinko et al., 1976) . The morphotypical R variants are not a preexisting subpopulation, but are continuously formed from E variants. This continuous transition explains the heterogeneity of the parental cell lines. Contamination of the cell lines is unlikely since we could confirm the absence of furin, a protease that is not expressed in LoVo due to mutational inactivation (Lehmann et al., 1998) , in our LoVo variants (Dr Fre´de´ric Andre´, Laboratory of Experimental Cancerology, personal communication).
We showed that noninvasive and invasive LoVo variants can be subcloned by their morphotype. Previously, we have also compared the in vivo behavior of LoVo-92R4 with that of the parental heterogenenous LoVo-92 cell line (Pocard et al., 2001) . In mice, surgical resection of orthotopically grafted LoVo-92 tumors led to 100% disease-free survival at 1 month while resection of orthotopically grafted LoVo-92R4 tumors led to only 30% of disease-free survival at 1 month. Indeed, 70% of mice grafted with the LoVo-92R4 cell line had mesenteric lymph node metastases (Pocard et al., 2001) . Our findings were in accordance with the findings of Re´my et al. (1992) who cloned the LoVoC5R variant that produced more lung metastases after subcutaneous injection in immunosuppressed newborn rats than its E counterpart.
We studied whether the E to R transition is associated with changes of the invasion-suppressor E-cadherin/ catenin complex. Taken together, our results demonstrate that the E to R transition in LoVo is accompanied Figure 5 Photomicrographs of paraffin sections from embryonic chick heart fragments confronted in organ culture during 7 days with noninvasive LoVoE1 (a) and invasive LoVo-92E1R1 (b) cells. Staining was with H&E. H, heart tissue. Arrow, epithelioid structures formed by LoVoE1 cells around the chick heart. Double arrows, LoVo-92E1R1 cells that have invaded into the heart tissue. Scale bar ¼ 100 mm Figure 6 Immunofluorescence photomicrographs of LoVoE15 (a, d, g), LoVoE15R1 (b, e and h) and LoVoE15R1 treated with TPA (c, f, i) immunostained with antibody against ZO-1 (a-c), against desmoplakin (d-f) or against E-cadherin (g-i). Note the presence of E-cadherin-negative cells in LoVoE15R1 (arrowheads). Scale bar ¼ 25 mm by downregulation, but not loss, of components of the E-cadherin/catenin complex and by loss of functionality of the E-cadherin/catenin complex. E variants, in contrast to R variants, form an E monolayer and domes (which represent vectorial transport and are a feature of cell polarity) on solid substratum, form aggregates that are resistant to pipetting and show E-cadherin-dependent compaction in a slow aggregation assay. The lower doubling times and higher saturation densities of R variants as compared to E variants are compatible with the loss of E-cadherin/catenin function. It is known that E-cadherin inhibits the proliferation of colon carcinoma cell lines through upregulation of the cyclin-dependent Kip1 in MCF-7 breast cancer cells results in higher doubling times and lower saturation densities (Sgambato et al., 1998) .
Another argument in favour of loss of functionality of the E-cadherin/catenin complex is the difference in the arrangement of tight junctional and desmosomal proteins in the R variants. Treatment with TPA could partially restore the E morphotype and induce the relocalization of ZO-1 and desmoplakin to the cell-cell contacts. The partial upregulation of intercellular adhesion and rearrangement of junctional proteins by TPA in cells with a nonfunctional E-cadherin/catenin complex are in accordance with the findings of van Hengel et al. (1997) and Cowell and Garrod (1999) . It is well known that PKC activators mediate the establishment of functional adherens junctions (Bracke et al., 1996) . Although the colonies on solid substratum appeared more compact, we could not induce compaction with 250 ng/ml TPA in a slow aggregation assay. It is however known that treatment with high TPA concentrations during longer times rather cause downregulation of PKC and inhibition of proliferation. Treatment with TPA reduced the expression of E-cadherin and plakoglobin in LoVo-92E1R1 cells, indicating that TPA acts probably downstream of the E-cadherin/catenin complex.
Others have correlated invasiveness of LoVo variants with reduced expression of the integrins a6b1 and a6b4, decreased ability to spread on laminin and disturbance of the organization of the peritumoral basement membrane (Dae´mi et al., 1995; Dumortier et al., 1998) . The impairment of the organization of the basement membrane and the lower expression of the laminin receptors might represent a feature of the lack of a polarized epithelial phenotype, for which the E-cadherin/complex is a major organizer (Fish and Molitoris, 1994; Bracke et al., 1996) . In this way b4 integrin could act downstream of the E-cadherin/catenin complex and upstream of MMP-2. Indeed, treatment of LoVo C5 cells with an anti-b4 integrin antibody resulted in stimulation of invasion and transcriptional activation of the MMP-2 gene (Dae´mi et al., 2000) . We also observed increased expression of active MMP-2 bands in LoVo-92E1R1 as compared to LoVoE1 as evidenced by gelatine zymography (our unpublished observations).
The loss of contact inhibition of motility and directional migration is a further argument for loss of E-cadherin function. The same phenomenon can be observed, in IGF-I-stimulated HT29-D4 cells that are treated with the E-cadherin functionally inhibiting antibody MB-2, in SIP1-overexpressing MDCK-Tetoff-SIP1 cells and in a-catenin deficient HCT-8/E11R1 cells (Andre´et al., 1999; Comijn et al., 2001, our unpublished observations) . The refringence of the perikarya of R cells is a feature of the absence of contact inhibition of ruffling and cell polarity (Mareel et al., 1981) . It is noteworthy that the parental LoVo cell line was obtained by peripheral growth from tumor explants (Drewinko et al., 1976) , which is a way to select for cells capable to perform directional migration. Our LoVo-92R4TD cell line kept the R morphotype of LoVo-92R4 after transplantation in the nude mouse. LoVo-92R4 is to our knowledge the first LoVo variant that is metastatic in a nude mouse model. The parental LoVo-92 cell line on the other hand is not metastatic in the nude mouse although it is derived from a metastasis (Drewinko et al., 1976; Pocard et al., 2001 ).
There were no indications for other differences of the E-cadherin/catenin complex. We could not precipitate phosphorylated b-catenin in LoVoE15 and LoVoE15R1 cells (our unpublished observations). We found no arguments for differences in glycosylation patterns of The significance of the other differentially expressed genes in LoVo-92E1R1 as compared to LoVoE1 is subject to further investigation. Notch 1 is expressed in neoplastic colon cancer tissue but not in normal glands (Zagouras et al., 1995) . Western blotting confirmed upregulation of the 300 kDa band of Notch 1 at the protein level in LoVo-92E1R1 cells as compared to LoVoE1 cells. There was however no difference in the expression of the active 110 kDa Notch 1 band (our unpublished observations). The significance of the alterations of mRNA signal of ephrin type-A receptor 2 precursor, LAR (leukocyte common antigen related) and RhoHP1 are unclear at present and need to be checked. Expression of ephrin type-A receptor 2 is regulated by E-cadherin as evidenced by the lower expression at mRNA and protein level in CDH1 À/À embryonic stem cells as compared to stem cells that were transfected with cDNA encoding CDH1 (Orsulic and Kemler, 2000) . The possibility of downregulation of LAR seems interesting as this protein-tyrosine phosphatase associates with b-catenin and plakoglobin. Moreover, ectopic expression of LAR in epithelial cells inhibits cell migration by preventing the phosphorylation and the increase in the free pool of b-catenin (Mu¨ller et al., 1999) .
The upregulation of E-cadherin mRNA and protein in R variants observed after treatment with 5-aza-2 0 -deoxycytidine as well as the presence of CDH1 promoter hypermethylation in LoVoE15R1 cells strongly suggests the implication of CDH1 promoter hypermethylation in the E to R transition. Wheeler et al. (2001) demonstrated the presence of CDH1 gene promoter hypermethylation in about 46% of colorectal cancers studied, underlining the clinical relevance of the LoVo model. In LoVo-92E1R1 cells, the negative result in the methylation-specific PCR experiment does not exclude CDH1 promoter hypermethylation. We have used only one primer pair set (Graff et al., 1997) assessing the methylation status of only 4-6 CpG dinucleotides. Heterogeneous and dynamic CDH1 hypermethylation was demonstrated in breast cancer cells where it appears that E-cadherin is temporarily downregulated, to facilitate invasion, and subsequently re-expressed in established metastases, to promote ectopic survival (Graff et al., 2000) . Downregulation of plakoglobin has been associated with morphotypical transition and invasion in human keratinocytes and fibroblasts (Boukamp and Fusenig, 1993; Tselepis et al., 1998) . Promoter hypermethylation of the plakoglobin gene, as described in thyroid carcinoma cell lines, is unlikely in our system because there was no significant effect of 5-aza-2 0 -deoxycytidine treatment in LoVo-92E1R1 cells (Po¨tter et al., 2001) .
Taken together, the LoVo model supports the hypothesis that heterogeneity and plasticity of expression of different cell adhesion molecules is essential for the E to R transition and acquisition of the invasive phenotype in human colorectal cancer cells.
Materials and methods
Cell cultures and reagents
Two samples of a human colon cancer cell line coined LoVo-92 and LoVo were obtained, respectively, from the laboratories of Dr MF Poupon and Dr F van Roy, who both purchased these from the American Type Culture Collection (ATCC, Rockville, MD, USA; CCL 229). The CCL 229 cell line is derived from a metastatic nodule in the left supraclavicular region of a 56-year old patient with histologically proven diagnosis of adenocarcinoma of the colon (Drewinko et al., 1976) . All other cell lines were derived from our LoVo-92 and LoVo subcultures through cloning or harvesting and selection for their E or R morphotype under phase contrast microscopy as described (Vermeulen et al., 1995a) . To obtain R variants, cultures were maintained with bi-weekly culture medium refreshment and weekly subculture. Conditioned media (2.5 ml), containing shed cells, were harvested weekly, admixed with 2.5 ml fresh culture medium and seeded onto a new 25-cm 2 tissue culture substrate to establish harvest cultures (Vermeulen et al., 1999b) .
The cell line LoVo-92 and its subclones were maintained in RPMI-1640 (Life Technologies, Ghent, Belgium), supplemented with 10% heat-inactivated fetal bovine serum (FBS), 250 IU/ml penicillin, 100 mg/ml streptomycin and 2.5 mg/ml fungizone (PSF). The cell line LoVo and its subclones were maintained in Ham's F-12 (Life Technologies) supplemented with 20% FBS and PSF. The tumor-derived (TD) cell strain LoVo-92R4TD was isolated from a subcutaneous nu/nu mouse tumor 8 weeks after s. c. injection of 5 Â 10 6 LoVo-92R4 cells in accordance with standard procedures (Van Hoorde et al., 2000) . All cell lines used and generated in the present study were mycoplasma-free (DAPI-staining, Sigma, St Louis, MO, USA). The concentration of TPA (Sigma) used was 250 ng/ml, the concentration of 5-aza-2 0 -deoxycytidine (Fluka Chemie GmbH, Steinheim, Germany) was 5 mmol/l, unless otherwise stated.
E and R variants from another colon cancer cell line HCT-8 were used for comparison in some experiments (Vermeulen et al., 1995a) .
Assays for growth
Cells (1 Â 10 5 ) were seeded on 25-cm 2 tissue culture substrate. The final numbers of viable cells grown after different incubation periods were counted in a Bu¨rker chamber after trypsin detachment and trypan blue (Sigma) staining. The exponential doubling times were calculated from the initial exponential phase of the growth curves with the following formula: '96 h/[log 2 (concentration at day 7)Àlog 2 (concentration at day 3)]'. The saturation densities were determined from the plateau of the growth curves as described (Brattain et al., 1981) .
Assays for cell-cell adhesion
To study the formation of multicellular spheroids on shaker, cells were detached, suspended in culture medium and kept under Gyrotory shaking (Gyrotory shaker; New Brunswick Scientific, New Brunswick, NJ, USA) at 80 r.p.m. for 3 days. For the dissociation assay, multicellular spheroids were evaluated microscopically before and after they were passed 30 times through Pasteur pipettes with a diameter of 1.5 mm (Takeda et al., 1995) .
In the slow aggregation assay, 20 000 cells were seeded on agar in a 96-well plate and incubated at 371C. Aggregate formation and compaction were scored with an inverted microscope after 24, 48 and 72 h. E-cadherin specificity of the aggregation and compaction was tested by addition, at the onset, of a functionally blocking antibody (MB2) (Bracke et al., 1993; Boterberg et al., 2001 ).
Wound-filling motility assay
The wound-filling motility assay was carried out as described (Chen et al., 1997; Polk, 1998) , with minor modifications. Cells were grown to confluency in 24-well plates. After 1 h incubation in calcium-free S-MEM (Eagle) spinner culture medium (Life Technologies), a scrape in the form of a cross was made through the confluent monolayer with a plastic pipette tip. Thereafter, the medium was refreshed, and the cultures were incubated for 6 days (with medium refreshment after 3 days). On the bottom of each well, four measuring points were marked. There were two wells per condition. After 3 or 6 days (depending upon the cell lines), the migration of wound edges, healing the wound area, was measured (in arbitrary units) under the microscope.
Assay for invasion in vitro
Aggregates, cell suspensions or monolayer fragments from LoVo variants were confronted with precultured fragments of embryonic chick heart. For evaluation of invasiveness, the interaction of confronting human cells with the heart tissue was scored on serial histological sections, and classified as grades 0-IV, as previously described (Mareel et al., 1979; Bracke et al., 2001) .
Immunoprecipitation, Western blotting and immunocytochemistry
Immunoprecipitation, Western blotting and immunocytochemistry were carried out as described earlier (Vermeulen et al., 1995a (Vermeulen et al., , 1999b Leroy et al., 2000) . We used the following antibodies: HECD-1 (Takara Shuzo, Kyoto, Japan) and MB2 mouse monoclonal antibodies against human E-cadherin; 'anti-catenin' a (Sigma) rabbit polyclonal antibody and affinity-purified rabbit polyclonal antibody #1597 raised against the aE-catenin-specific synthetic peptide C-HVDPVQALSEFK (Vermeulen et al., 1995a) ; 'anti-catenin b' (Sigma) rabbit polyclonal antibody and affinity-purified rabbit polyclonal antibody #1522, raised against the b-cateninspecific synthetic peptide C-PGDSNQLAWFDTDL (Vermeulen et al., 1995b); mouse monoclonal antibody PG 5.1 against plakoglobin (Research Dianostics Inc., Flanders, NJ, USA); mouse monoclonal antibody pp120 (Transduction Laboratories, Lexington, KY, USA) against mouse and human p120 ctn ; mouse monoclonal antibody DP 2.15 against desmoplakin I and II (Boehringer Mannheim, Mannheim, Germany); rabbit polyclonal antibody anti-ZO-1 and ZO-2 (Zymed, San Francisco, CA, USA); rat monoclonal antibody MOC37 against occludin (kindly provided by M Furuse, Kyoto, Japan); goat polyclonal antibody against human b4-integrin (sc-6629; Santa Cruz Biotechnology, Santa Cruz, CA, USA); mouse monoclonal antibody B-5-1-2 (Sigma) against a-tubulin. Secondary alkaline phosphatase and horseradish peroxidase-conjugated antibodies were from Sigma and Amersham Pharmacia Biotech (Buckinghamshire, UK), respectively. ECL staining reagent was from Amersham Pharmacia Biotech. Immunoblots were quantified using Quantity One Software (Bio-Rad Laboratories, Hercules, CA, USA) where indicated.
Analysis of differential gene expression using cDNA arrays
Atlas Human Cell Interaction cDNA Expression Array (spotted with 265 genes; catalog number 7746-1; Clontech, Palo Alto, CA, USA) was used to analyse the differential gene expression in noninvasive LoVo-92E1 and invasive LoVo-92E1R1 cells. Isolation of mRNA, cDNA synthesis and labeling of cDNA were done using the Atlas Pure Total RNA Labeling System (Clontech). Hybridization of cDNA probes to the Atlas Array filters was performed according to the manufacturer's protocol (Clontech). After hybridization and washing, the array filters were scanned using a phosphorimager (Bio-Rad Laboratories) and analysed with AtlasImage 2.0 software according to the manufacturer's instructions (Clontech).
Methylation-specific PCR
CDH1 promoter methylation analysis was performed using methylation-specific PCR according to the method described by Herman et al. (1996) and using primers described by Graff et al. (1997) for the CpG island 3 of the CDH1 promoter.
Real-time quantitative RT-PCR
We extracted total RNA from cell lines using the Rneasy kit (Qiagen). We determined CDH1 mRNA levels relative to those for TBP after reverse transcription coupled to the real-time PCR using an ABIprism 7700 Sequence Detection System and the qPCR MasterMix (Eurogentec). Sequences of primers used for the CDH1 gene were 5 0 -gtcactgacaccaacgataatcct-3 0 and 5 0 -tttcagtgtggtgattacgacgtta-3 0 and for the JUP gene were 5 0 -cccagcgccacgtagct-3 0 and 5 0 -cacaatctcctccatcctcaca-3 0 . The Taqman probe sequence was 5 0 -FAM-ttccaatcccaccacgtacaagggtcag-TAMRA-3 0 and 5 0 -FAM-aggcacacagcagccctacacggat-TAMRA-3 0 . PCR amplification, standard curve construction and normalization were performed as described previously (Bie`che et al., 1999) .
Statistics
The nonparametric Mann-Whitney U test was used to study differences in the wound-filling motility assay.
